Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/25013
DC FieldValueLanguage
dc.contributor.authorYashar, Genghisen_US
dc.contributor.authorBasheska, Nelien_US
dc.contributor.authorIvkovski, Ljubeen_US
dc.contributor.authorKubelka, Katerinaen_US
dc.contributor.authorZografski, Georgeen_US
dc.date.accessioned2022-12-19T13:06:22Z-
dc.date.available2022-12-19T13:06:22Z-
dc.date.issued2001-09-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/25013-
dc.description.abstractIntroduction: Adenomyoepithelioma (AME), and especially myoepithelial carcinoma (MC), the malignant variant of this tumor, is a rare breast neoplasm. This report comprises the pathological features of a breast MC arising in AME with an aggressive clinical course. Case report: A 48-year old woman with a palpable mass in the right breast was admitted in November 1998. A month later following FNAB, surgical excision was performed. During the follow-up period of 17 months, until the patient's death, two local recurrences developed. Despite the aggressive chemotherapy, administrated after the first recurrence, subsequently bone, pulmonary and brain metastases appeared. Results: The primary tumor was an ovoid, white-grey, encapsulated mass measuring 4x3,5x1,5 cm. Microscopically, this biphasic tumor was composed of rare tubules surrounded by interlacing bundles of spindle cells exhibiting mild atypia. It was initially classified as a benign phyllodes tumor. The immunohistochemical analyses performed after the second recurrence proved the myoepithelial origin of the neoplasm (S-100, cytokeratin and alpha-SMA positive cells), with a high mitotic index (11 MF/10 HPF), and an immunophenotype indicating aggressive biological potential (steroid receptor negative, 50% Ki-67 and 30% p53 positive cells). Therefore, it was reclassified as MC arising in spindle cell type of AME. Conclusion: The histopathological diagnosis of AME could be very difficult, especially when a distinction from other spindle cell breast neoplasms must be done. Immunohistochemistry is essential to confirm the diagnosis, having in mind the reported pathological characteristics and the immunohistochemical profile of recurrent and malignant tumors of this type.en_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofVirchows Archiven_US
dc.subjectbreasten_US
dc.subjectadenomyoepitheliomaen_US
dc.subjectmyoepithelial carcinomaen_US
dc.subjecthistopathologyen_US
dc.subjectimmunohistochemistryen_US
dc.titleMyoepithelial carcinoma of the breast arising in adenomyoepithelioma. A case report.en_US
dc.typeProceeding articleen_US
dc.relation.conference18th European Congress of Pathology, September 8-13, 2001, Berlin, Germanyen_US
dc.identifier.doi10.1007/BF02698641-
item.grantfulltextopen-
item.fulltextWith Fulltext-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Conference papers
Files in This Item:
File Description SizeFormat 
ECP 2001 pp451-2.pdf459.21 kBAdobe PDFView/Open
ECP 2001 cover.pdf75.39 kBAdobe PDFView/Open
Show simple item record

Page view(s)

33
checked on May 10, 2024

Download(s)

8
checked on May 10, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.